Author:
Garrison Louis P.,Jiao Boshen,Elsisi Zizi,Yehoshua Alon,Koruth Roy,Kreter Bruce,Grueger Jens
Reference33 articles.
1. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States;Chhatwal;Ann Intern Med,2015
2. Cost-effectiveness of early treatment of hepatitis C virus genotype 1 by stage of liver fibrosis in a US treatment-naive population;Chahal;JAMA Intern Med,2016
3. A national hepatitis C elimination program in the United States: a historic opportunity;Fleurence;JAMA,2023
4. Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C;Jiang;J Manag Care Spec Pharm,2021
5. The Lower Drug Costs Now Act and Pharmaceutical Innovation: Insights From Industry Interviews and Elicitation;Hitch,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献